share_log

Press Release: Aphex BioCleanse Systems Appoints Tom Fitzgerald as Chairman of the Board; Adds Scott Buckley as New Board Member

Press Release: Aphex BioCleanse Systems Appoints Tom Fitzgerald as Chairman of the Board; Adds Scott Buckley as New Board Member

新聞稿:Aphex BioCleanse Systems任命湯姆·菲茨傑拉德為董事會主席;增加斯科特·巴克利為新董事會成員
Dow Jones Newswires ·  2021/09/29 09:09

Press Release: Aphex BioCleanse Systems Appoints Tom Fitzgerald as Chairman of the Board; Adds Scott Buckley as New Board Member

新聞稿:Aphex BioCleanse Systems任命湯姆·菲茨傑拉德為董事會主席;增加斯科特·巴克利為新董事會成員

Aphex BioCleanse Systems Appoints Tom Fitzgerald as Chairman of the Board; Adds Scott Buckley as New Board Member

Aphex BioCleanse Systems任命湯姆·菲茨傑拉德為董事會主席;增加斯科特·巴克利為新董事會成員

PR Newswire

美通社

PITTSFORD, N.Y., Sept. 29, 2021

紐約州皮茨福德,9月2021年2月29日

PITTSFORD, N.Y., Sept. 29, 2021 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company"), a cleaning solutions company focused on the development and distribution of non-toxic and water-based cleaning products trademarked with Hy-IQ(R) Water, today announced that the Company has appointed Tom Fitzgerald as Chairman of the Board and Director of Operations Scott Buckley as a member of the Board of Directors.

紐約州皮茨福德,9月亞洲網2021年3月29日電清潔解決方案公司Aphex BioCleanse Systems,Inc.(OTCPK:SNST)(以下簡稱“Aphex”或“本公司”)今天宣佈,該公司已任命湯姆·菲茨傑拉德為董事會主席,並任命斯科特·巴克利為董事會成員。Aphex BioCleanse Systems,Inc.(場外交易代碼:SNST)是一家專注於開發和分銷以Hy-IQ(R)Water為商標的無毒水基清潔產品的清潔解決方案公司。

"I believe Aphex has a unique opportunity to change the landscape of cleaning products through its proprietary, non-toxic cleaning solution, Hy-IQ(R) Water," said Tom Fitzgerald, Aphex's newly appointed Chairman of the Board. "I plan to leverage my years of experience working with regulatory bodies and large, publicly traded companies in the life sciences sector in order to take Aphex to the next level. I hope to assist the Aphex management team and Board of Directors with filling the imminent market need for environmentally-friendly, safe sanitization products."

Aphex新任命的董事會主席Tom Fitzgerald説:“我相信Aphex有一個獨特的機會,可以通過其專有的無毒清潔解決方案Hy-IQ(R)Water改變清潔產品的面貌。我計劃利用我在生命科學領域與監管機構和大型上市公司合作的多年經驗,將Aphex提升到一個新的水平。我希望協助Aphex管理團隊和董事會滿足對環保、安全的消毒產品的迫切市場需求。“

Fitzgerald is a seasoned business professional and visionary leader with more than 35 years of experience as an attorney, senior executive and consultant in the biopharmaceutical and consumer products industries. He has held numerous positions on the Board of Directors for both public and private domestic and international entities and has led a variety of companies to pursue regulatory and legal compliance approvals for a variety of products, prescription drugs, over-the-counter (OTC) medicines, medical devices and drug delivery systems. He has also managed joint ventures and strategic alliances between major pharmaceutical companies and accredited manufacturing facilities in the US and the EU. Fitzgerald is a graduate of Boston College, Chestnut Hill MA and the St. John's University School of Law. He has been admitted to practice law in New York and Connecticut state and federal courts.

菲茨傑拉德是一位經驗豐富的商業專業人士和富有遠見的領導者,在生物製藥和消費品行業擔任律師、高級管理人員和顧問超過35年的經驗。他在國內外公共和私營實體的董事會中擔任過多個職位,並領導多家公司為各種產品、處方藥、非處方藥、醫療器械和藥物輸送系統尋求法規和法律合規性批准。他還管理着大型製藥公司與美國和歐盟經認可的製造設施之間的合資企業和戰略聯盟。菲茨傑拉德畢業於波士頓學院、馬薩諸塞州栗子山學院和聖約翰大學法學院。他已獲准在紐約州、康涅狄格州和聯邦法院執業。

Buckley has served as Director of Operations for the Company since 2007. He manages all physical operations, including facility maintenance, production, and logistics. Buckley has more than 14 years of experience in operational functions, and has been instrumental in helping Aphex develop corporate strategy for production, purchasing and distribution. He has developed many core policies and procedures that guarantee streamlined supply chain activities, controlled budgets, and a safe working environment.

巴克利自2007年以來一直擔任該公司的運營總監。他管理所有的物理操作,包括設施維護、生產和物流。巴克利在運營職能部門擁有14年以上的經驗,在幫助Aphex制定生產、採購和分銷的公司戰略方面發揮了重要作用。他制定了許多核心政策和程序,以保證簡化供應鏈活動、控制預算和安全的工作環境。

"I've been the Director of Operations for Aphex since its inception, helping with the development and research of Hy-IQ(R) Water, and it's an honor to be able to continue to serve the Company's mission in this capacity," said Scott Buckley, Aphex's newest Board member. "I am confident that the future of Aphex is bright because of its strong intellectual property and commitment to coming up with creative, effective solutions to some of the world's largest problems."

Aphex的最新董事會成員Scott Buckley説:“自Aphex成立以來,我一直擔任Aphex的運營總監,幫助Hy-IQ(R)Water的開發和研究,能夠繼續以這一身份為公司的使命服務是一種榮幸。”我相信Aphex的未來是光明的,因為它擁有強大的知識產權,並致力於為世界上一些最大的問題提供創造性的、有效的解決方案。“

About Aphex BioCleanse Systems, Inc.

Aphex BioCleanse系統公司簡介

Aphex BioCleanse Systems, Inc is the developer of the world's first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology. The technology, called Hy-IQ(R) Water, has a unique method of cleaning that uses hydrogen ions. Learn more about Aphex at www.aphexus.com.

Aphex BioCleanse Systems,Inc.是世界上第一個專有的無酒精、無毒和氫基清潔技術的開發商。這項名為Hy-IQ(R)Water的技術有一種獨特的使用氫離子的清潔方法。欲瞭解有關Aphex的更多信息,請訪問www.aphexus.com。

FDA Statement

FDA聲明

The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

本文檔中的陳述未經FDA評估或批准。本文檔中引用的產品和聲明不用於診斷、治療、治癒或預防任何疾病。

Safe Harbor Statement

安全港聲明

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

本新聞稿包含1933年“證券法”第27A節和1934年“證券交易法”第21E節所指的前瞻性陳述。這些前瞻性陳述基於管理層當前的計劃和預期,可能會受到一些不確定性和風險的影響,這些不確定性和風險可能會對公司當前的計劃和預期以及未來的經營結果和財務狀況產生重大影響。公司不承擔公開更新或修改任何前瞻性陳述的義務,無論是由於新信息、未來事件還是其他原因。

Contact:

聯繫方式:

ShareholderInfo@aphexus.com

郵箱:ShareholderInfo@aphexus.com

www.aphexus.com

Www.aphexus.com

Phone: 1-585-386-0990

電話:1-585-386-0990

Address:

地址:

Aphex BioCleanse Systems Inc.

Aphex BioCleanse Systems Inc.

1162 Pittsford Victor Road Ste 220

匹茲福德維克多路220號1162號

Pittsford, NY 14534

郵編:14534,紐約州皮茨福德

For Aphex media inquiries, please contact:

有關Aphex媒體的查詢,請聯繫:

Kathryn Brown

凱瑟琳·布朗

aphex@cmwmedia.com

郵箱:Aphex@cmwmedia.com

858-264-6600

858-264-6600

www.cmwmedia.com

Www.cmwmedia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/aphex-biocleanse-systems-appoints-tom-fitzgerald-as-chairman-of-the-board-adds-scott-buckley-as-new-board-member-301387655.html

查看原創內容以下載multimedia:https://www.prnewswire.com/news-releases/aphex-biocleanse-systems-appoints-tom-fitzgerald-as-chairman-of-the-board-adds-scott-buckley-as-new-board-member-301387655.html

SOURCE Aphex BioCleanse Systems, Inc.

來源:Aphex BioCleanse Systems,Inc.

/Web site: http://www.aphexus.com

網址:http://www.aphexus.com

(END) Dow Jones Newswires

(完)道瓊通訊社

September 29, 2021 09:09 ET (13:09 GMT)

2021年9月29日東部時間09:09(格林尼治標準時間13:09)

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論